|
0–4 yr.
n=310
|
5–17 yr.
n=59
|
18–59 yr.
n=76
|
≥60 yr.
n=152
|
P-value
|
Treatments |
|
|
|
|
|
Vasoactive drug |
6 (1.9%) |
1 (1.7%) |
1 (1.3%) |
6 (3.9%) |
0.573 |
Antiviral treatment |
19 (6.1%) |
1 (1.7%) |
7 (9.2%) |
7 (4.6%) |
0.288 |
Antibiotics |
188 (60.6%) |
30 (50.8%) |
35 (46.1%) |
113 (74.3%) |
<0.001 |
Corticosteroids |
61 (19.7%) |
11 (18.6%) |
10 (13.2%) |
24 (15.8%) |
0.509 |
Oxygen therapy |
39 (12.6%) |
2 (3.4%) |
27 (35.5%) |
95 (62.5%) |
<0.001 |
Mechanical ventilation |
26 (8.4%) |
0 (0%) |
6 (7.9%) |
19 (12.5%) |
0.035 |
noninvasive
|
25 (8.1%)
|
0 (0%)
|
4 (5.3%)
|
7 (4.6%)
|
<0.001
|